Kadenwood’s EcoGen Biosciences Acquires Hemp Processing Company, Adding Increased Production Capacity and cGMP Certification


Ryan Allway

November 13th, 2020

News, Top News


GRAND JUNCTION, Colo.Nov. 12, 2020 /PRNewswire/ — Kadenwood’s EcoGen Biosciences (“EcoGen” or the “Company”), a  leading vertically-integrated manufacturer and supplier of hemp-derived specialty ingredients, proprietary formulations, and private-label finished products in the United States, announced today the acquisition of Colorado-based hemp processing and extraction company General Processing LLC (“GP, LLC”). This acquisition will substantially expand EcoGen’s production capacity, adding technological innovations in the areas of sustainability and current Good Manufacturing Practice (cGMP) compliance. This allows the Company to further integrate its own supply chain while servicing domestic and global markets.

Through proprietary internal research and development, paired with innovative process IP  included in the acquisition, the Company has advanced its commitment to implement a more sustainable  production of raw hemp materials. The newly added facility will remove entire stages of the process, allowing for the reduction of waste through proprietary equipment and processes. As part of its ongoing operational strategic planning, EcoGen has placed sustainability and innovation at the forefront of its strategic expansion plan, looking to remain the industry leader and set the standard for sustainable hemp manufacturing practices.

As a part of the acquisition, the Company has added a 50,000-square-foot production campus in Delta, Colorado, with an additional 165 acres of farming land. The facility recently completed a dietary supplements cGMP inspection for 21 CFR Part 111 certification conducted by ASI on October 4, 2020, which was ahead of the expected schedule and expedited EcoGen’s compliance plan to include dietary supplement certification substantially. This certification will further position EcoGen for future regulatory compliance standards set by various regulatory agencies and allows for its products to meet industry-leading standards for the highest quality products available. The Company looks to develop the facility in the coming months.

Included in its offering are raw hemp materials such as isolate and distillate, custom formulated hemp-derived products and general processing of hemp biomass for use in consumer-facing products of all kinds.

“This acquisition not only expedites the process of garnering cGMP certification for our manufacturing capabilities, but allows us space to introduce our revolutionary new sustainable manufacturing processes while expanding our capacity as we look ahead to 2021 and prepare for increasing demand,” said Garrett Bain, President of EcoGen Biosciences. “As a global, leading vertically-integrated manufacturer and supplier of hemp-derived specialty ingredients, EcoGen values quality, integrity and consistency above all else. In order to maintain this industry-leading position, we continue to take forward-looking steps that will enable our products and processes to continue to meet customer needs as evolving regulatory and health authority standards are applied to the hemp extraction and hemp-derived products industry.

“With this newest acquisition that adds further value to EcoGen’s capabilities, we are positioning Kadenwood to be a global powerhouse of hemp-derived raw materials and consumer products of the highest caliber,” said Erick Dickens, CEO and Co-Founder of Kadenwood. “Through our strategic growth plan, we will continue to evolve as an organization, staying ahead of production and product trends. While many companies have struggled to define their role in this evolving and competitive landscape, Kadenwood has emerged as the industry’s true leader. We are proud to lead in products, manufacturing, innovation, and now, sustainability and compliance. We look to the future with optimism, as we are confident that 2021 and beyond will continue to provide great success and opportunities for Kadenwood companies.”

EcoGen is the lead manufacturing arm of Kadenwood, LLC, a consumer seed-to-shelf CBD company dedicated to fostering trust and transparency in the mainstream wellness category, after its recent acquisition. The Company supplies the raw hemp materials for use in Kadenwood’s CBD products, as well as many other brands across North America and Europe.

For more information on the Company and its products please visit https://www.kadenwoodbrands.com/. For more information on EcoGen including information on becoming a customer, please visit https://ecogenbiosciences.com/.

About Kadenwood, LLC
Founded in 2019, Kadenwood is a privately held consumer products lifestyle company relentlessly focused on shaping CBD into a trusted and safe mainstream wellness category. To drive this mission, Kadenwood is backed by decades of CPG marketing and category innovation expertise and industry-leading, vertically-integrated CBD farming to ensure quality CBD oil from seed-to-shelf that contains no THC. In 2019, Kadenwood launched its first branded products under LEVEL SELECT™ in personal care.

About EcoGen Biosciences
EcoGen Biosciences (EcoGen) is the leading vertically-integrated manufacturer and supplier of hemp-derived specialty ingredients in North America. Using proprietary equipment, processes, and formulations, EcoGen has developed a broad range of the highest quality ingredients and customized formulations for a broad range of industries. Founded in 2016, EcoGen is the first seed-to-sale CBD manufacturer, known for manufacturing the purest CBD raw materials and finished products. The company is also a leader in international distribution with CBD isolate, water-soluble CBD (Nano), and THC-free CBD distillate. As the leader in hemp genetics, EcoGen promotes sustainable agriculture, using its proprietary processing and extraction technology to ensure the highest quality products at the lowest price making cannabinoids more accessible to the world.

Public Relations Contact:
Brian Price
CMW Media
[email protected]
(609) 206-1812

SOURCE Kadenwood

Related Links

https://ecogenbiosciences.com

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

Ryan Allway

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading